CHINA NATIONAL MEDICINES CORPORATION LTD.

Altre lingue China National Medicines Corporation Ltd.

Azioni

600511

CNE000001D56

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 07/06/2024			Variaz. 5gg	Var. 1 gen.
34,38 ^CNY	-2,63%		+0,59%	+20,13%

25/04	China National Medicines Corporation Ltd. Riporta i risultati degli utili per il primo trimestre terminato il 31 marzo 2024	CI
21/03	Le azioni cinesi chiudono in sordina, mentre l'ottimismo per la ripresa si affievolisce; Sinopharm salta del 6% grazie agli utili del 2023.	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	21/03
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	21/03
China National Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
China National Medicines Deputy Manager Under Probe for Alleged Insider Trading	10/01
CASI Pharmaceuticals, Inc. Enters into an Exclusive Distribution Agreement with China National Medicines Corporation Ltd	08/12
China National Medicines' Profit Drops 16.1% in Q3	25/10/23
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23
Sinopharm CFO Retires; Successor Named	16/10/23
China National Medicines Corporation Ltd.(XSSC:600511) added to S&P Global BMI Index	18/09/23
China National Medicines Corporation Ltd.(XSSC:600511) added to FTSE All-World Index	18/09/23
China National Medicines' Profit Climbs 14.2% in H1	24/08/23
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23
China National Medicines' Q1 Profit Rises 10.9%	26/04/23
China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Sinopharm’s Profit Rises 12% in 2022; Revenue Slips 2%	23/03/23
China National Medicines' 2022 Profit Up 12%	23/03/23
Sinopharm Eyes Production of Merck's COVID-19 Drug in China	13/01/23
Sinopharm Clarifies It Is Not A Distributor for Pfizer's COVID-19 Drug	20/12/22
Sinopharm to Buy $168 Million Shares in Shyndec Pharma	30/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue China National Medicines Corporation Ltd.

Azioni

600511

CNE000001D56

Altre lingue

Filtri